Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

umbilical cord blood-derived CD4+/CD25+ T-regulatory cells CK0801

A preparation composed of allogeneic umbilical cord blood (UCB)-derived, ex vivo expanded and enhanced CD4+/CD25+ T-regulatory cells (Tregs) with potential immunomodulatory activity. Upon administration, the UCB-derived CD4+/CD25+ Tregs CK0801 may promote immunologic homeostasis and prevent autoimmunity by suppressing self-reactive T cells. This may induce tolerance to allogeneic organ transplants, prevent graft-versus-host disease (GvHD), and suppress autoimmune pathology.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:UCB-derived CD4+CD25+ Tregs CK0801
Code name:CK 0801
CK-0801
CK0801
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search